All Reviews/Perspectives

  1. Wood, K.C. (2020). Overcoming MCL-1-driven adaptive resistance to targeted therapies, Nature Communications 11, 531. [Pubmed][PDF]
  2. Winter, P.S.; Wood, K.C. (2018). Mapping effector-phenotype landscapes in KRAS-driven cancers, Trends in Cancer 4, 333-335. [Pubmed][PDF]
  3. Wood, K.C. (2017). Suppressing oncogenic transcription with a little healthy competition, Science Translational Medicine 9, 374eaaI5000. [Link]
  4. Wood, K.C. (2016). An EXITS strategy for decreasing cancer risk in women, Science Translational Medicine 8, 368ec197. [Link]
  5. Wood, K.C. (2016). Hacking T cells with synthetic circuits to program antitumor responses, Science Translational Medicine 8, 362ec172. [Link]
  6. Singleton, K.R.; Wood, K.C. (2016). Narrowing the focus: A toolkit to systematically connect oncogenic signaling pathways with cancer phenotypes, Genes Cancer 7(7-8), 218-228. [PDF][Pubmed]
  7. Wood, K.C. (2016). Two faces of circulating breast cancer cells, Science Translational Medicine 8(356), 356ec149. [Link]
  8. Wood, K.C. (2016). Mapping a path for precision cancer therapies, Science Translational Medicine 8(348), 348ec115.[Link]
  9. Wood, K.C. (2016). Targeting the cancer cells that just won’t go away, Science Translational Medicine 8(344), 344ec101. [Link]
  10. Wood, K.C. (2016). Collaborating tumor cells overcome multitargeted antiangiogenic therapies, Science Translational Medicine 8(338), 338ec77. [Link]
  11. Wood, K.C. (2016). Intercepting reversible drug tolerance to improve targeted therapy, Science Translational Medicine 8(322), 332ec52. [Link]
  12. Wood, K.C. (2015). Mapping the pathways of resistance to targeted therapies, Cancer Research 75, 4247-51. [PDF] [Pubmed]
  13. Wood, K.C.; Sabatini, D.M. (2009). Growth signaling at the nexus of stem cell life and death, Cell Stem Cell 5, 232-234. [Pubmed] [PDF]